Suzanne Norval

2.6k total citations
17 papers, 673 citations indexed

About

Suzanne Norval is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Organic Chemistry. According to data from OpenAlex, Suzanne Norval has authored 17 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Public Health, Environmental and Occupational Health and 8 papers in Organic Chemistry. Recurrent topics in Suzanne Norval's work include Trypanosoma species research and implications (13 papers), Research on Leishmaniasis Studies (9 papers) and Synthesis and Biological Evaluation (7 papers). Suzanne Norval is often cited by papers focused on Trypanosoma species research and implications (13 papers), Research on Leishmaniasis Studies (9 papers) and Synthesis and Biological Evaluation (7 papers). Suzanne Norval collaborates with scholars based in United Kingdom, Norway and Switzerland. Suzanne Norval's co-authors include Kevin D. Read, Alan H. Fairlamb, Laste Stojanovski, Susan Wyllie, Stephen Patterson, Frederick R. C. Simeons, Ian H. Gilbert, Robert Kime, Paul G. Wyatt and Julie A. Frearson and has published in prestigious journals such as PLoS ONE, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

Suzanne Norval

17 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Norval United Kingdom 14 360 356 329 190 55 17 673
Laste Stojanovski United Kingdom 12 329 0.9× 352 1.0× 251 0.8× 195 1.0× 47 0.9× 15 611
Deuan C. Jones United Kingdom 15 369 1.0× 423 1.2× 285 0.9× 279 1.5× 38 0.7× 18 690
Carolina Carrillo Argentina 18 274 0.8× 465 1.3× 216 0.7× 324 1.7× 69 1.3× 47 660
L.B. Tulloch United Kingdom 17 275 0.8× 307 0.9× 267 0.8× 495 2.6× 34 0.6× 28 820
James H. McKie United Kingdom 14 312 0.9× 228 0.6× 231 0.7× 431 2.3× 31 0.6× 28 747
Andrea Montalvetti United States 14 268 0.7× 385 1.1× 220 0.7× 447 2.4× 59 1.1× 14 766
Valérie Landry France 13 163 0.5× 194 0.5× 289 0.9× 211 1.1× 14 0.3× 22 622
Marcos Veríssimo de Oliveira Cardoso Brazil 19 389 1.1× 391 1.1× 701 2.1× 218 1.1× 42 0.8× 34 941
Rahul Shivahare India 17 371 1.0× 233 0.7× 526 1.6× 155 0.8× 39 0.7× 26 767
Neil R. Norcross United Kingdom 9 156 0.4× 149 0.4× 156 0.5× 119 0.6× 36 0.7× 14 363

Countries citing papers authored by Suzanne Norval

Since Specialization
Citations

This map shows the geographic impact of Suzanne Norval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Norval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Norval more than expected).

Fields of papers citing papers by Suzanne Norval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Norval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Norval. The network helps show where Suzanne Norval may publish in the future.

Co-authorship network of co-authors of Suzanne Norval

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Norval. A scholar is included among the top collaborators of Suzanne Norval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Norval. Suzanne Norval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Harrison, Justin R., Stephen Brand, Victoria Smith, et al.. (2018). A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N -Myristoyltransferase Inhibitors. Journal of Medicinal Chemistry. 61(18). 8374–8389. 46 indexed citations
2.
Wall, Richard J., Sónia Moniz, Michael G. Thomas, et al.. (2018). Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition Metals. Antimicrobial Agents and Chemotherapy. 62(8). 22 indexed citations
3.
Scullion, Paul, et al.. (2018). A role for trypanosomatid aldo-keto reductases in methylglyoxal, prostaglandin and isoprostane metabolism. Biochemical Journal. 475(16). 2593–2610. 13 indexed citations
4.
Bayliss, Tracy, David A. Robinson, Victoria Smith, et al.. (2017). Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors. Journal of Medicinal Chemistry. 60(23). 9790–9806. 16 indexed citations
5.
Wyllie, Susan, Suzanne Norval, Stephen Patterson, et al.. (2016). Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania. PLoS Pathogens. 12(11). e1005971–e1005971. 67 indexed citations
6.
Patterson, Stephen, Susan Wyllie, Suzanne Norval, et al.. (2016). The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis. eLife. 5. 61 indexed citations
7.
Spinks, Daniel, Victoria Smith, Stephen Thompson, et al.. (2015). Development of Small‐Molecule Trypanosoma brucei N‐Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode. ChemMedChem. 10(11). 1821–1836. 18 indexed citations
8.
Cleghorn, Laura A. T., Sébastien Albrecht, Laste Stojanovski, et al.. (2015). Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors ofTrypanosoma brucei. Journal of Medicinal Chemistry. 58(19). 7695–7706. 25 indexed citations
9.
Woodland, Andrew, Stephen Thompson, Laura A. T. Cleghorn, et al.. (2015). Discovery of Inhibitors of Trypanosoma brucei by Phenotypic Screening of a Focused Protein Kinase Library. ChemMedChem. 10(11). 1809–1820. 11 indexed citations
10.
Kaiser, Marcel, Karen L. White, Suzanne Norval, et al.. (2013). Structure–Activity Relationship Studies of Pyrrolone Antimalarial Agents. ChemMedChem. 8(9). 1537–1544. 34 indexed citations
11.
Patterson, Stephen, Susan Wyllie, Laste Stojanovski, et al.. (2013). The R Enantiomer of the Antitubercular Drug PA-824 as a Potential Oral Treatment for Visceral Leishmaniasis. Antimicrobial Agents and Chemotherapy. 57(10). 4699–4706. 53 indexed citations
12.
Reilly, Louise, et al.. (2012). Skin-Targeted Inhibition of PPAR β/δ by Selective Antagonists to Treat PPAR β/δ – Mediated Psoriasis-Like Skin Disease In Vivo. PLoS ONE. 7(5). e37097–e37097. 31 indexed citations
13.
Wyllie, Susan, Stephen Patterson, Laste Stojanovski, et al.. (2012). The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis. Science Translational Medicine. 4(119). 119re1–119re1. 123 indexed citations
14.
Smith, Victoria, Laura A. T. Cleghorn, Andrew Woodland, et al.. (2011). Optimisation of the Anti‐Trypanosoma brucei Activity of the Opioid Agonist U50488. ChemMedChem. 6(10). 1832–1840. 6 indexed citations
15.
Milner, Erin, Jason Sousa, Brandon Pybus, et al.. (2011). Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum. European Journal of Drug Metabolism and Pharmacokinetics. 36(3). 151–158. 6 indexed citations
16.
Brand, Stephen, Laura A. T. Cleghorn, Stuart P. McElroy, et al.. (2011). Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors. Journal of Medicinal Chemistry. 55(1). 140–152. 93 indexed citations
17.
Ruda, G.F., Pui Ee Wong, Vincent Pius Alibu, et al.. (2010). Aryl Phosphoramidates of 5-Phospho Erythronohydroxamic Acid, A New Class of Potent Trypanocidal Compounds. Journal of Medicinal Chemistry. 53(16). 6071–6078. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026